Degapt 120 mg Injection 1's

Degapt 120 mg Injection 1's belongs to the group of medicines called gonadotropin-releasing hormone receptor antagonists indicated in the treatment of advanced prostate cancer. Prostate cancer is a cancer that occurs in the man’s prostate, a male reproductive gland.

Degapt 120 mg Injection 1's contains Degarelix, a synthetic hormone blocker which works by decreasing the amount of testosterone and helps to stop or slow the spread of prostate cancer cells that require testosterone for their growth.

In some cases, Degapt 120 mg Injection 1's may cause side effects such as injection site reaction and hot flushes. Most of these side effects may not require medical attention and resolve gradually over time. However, if any of the side effects persist or worsen, consult your doctor.

Let the doctor know if you are allergic to any of the components in Degapt 120 mg Injection 1's. This medicine is not intended for use in women. Degapt 120 mg Injection 1's is not recommended for use in children. Inform your doctor about your health condition and medications to rule out any side effects/interactions.

Degapt 120 mg Injection 1's belongs to the group of medicines called gonadotropin-releasing hormone receptor antagonists indicated in the treatment of adult male patients with prostate cancer and high-risk prostate cancer before radiation therapy and in combination with radiotherapy. Degapt 120 mg Injection 1's contains Degarelix, a synthetic hormone blocker which works by decreasing the amount of testosterone and helps to stop or slow the spread of prostate cancer cells that require testosterone for their growth. Thereby, it helps treat prostate cancer.

• Injection site reactions (pain, redness, swelling)
• Hot flushes
• Weight gain
• Nausea
• Diarrhoea
• Dizziness
• Headache
• Tiredness

Do not use Degapt 120 mg Injection 1's if you are allergic to any of its components. Inform the doctor if you have heart rhythm problems, diabetes mellitus, osteoporosis, heart, liver or kidney problems, high blood pressure, or high/low blood levels of calcium, potassium, magnesium, or sodium in your blood. Avoid rubbing or scratching the injection site. After you receive a dose of Degapt 120 mg Injection 1's, avoid allowing your body fluids to come into contact with your hands or other surfaces for at least 48 hours. Let the doctor know if you are taking any prescription/non-prescription medications, including herbal products and supplements.

Drug-Drug Interactions: Inform the doctor if you are taking drugs used to treat heart rhythm problems (quinidine, procainamide, amiodarone, sotalol), pain killers (methadone), antibiotics (moxifloxacin), and antipsychotics.

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: Inform the doctor if you have heart rhythm problems, diabetes mellitus, or osteoporosis.

• QUINIDINE
• PROCAINAMIDE
• AMIODARONE
• SOTALOL
• METHADONE
• MOXIFLOXACIN

• Eat a healthy diet and exercise regularly to maintain proper weight.
• Avoid smoking and alcohol consumption.
• Avoid fast, fried, processed meats, refined carbs, and added sugar.
• Get optimal sleep; rest well.

Prostate cancer: Prostate cancer, also called prostatic carcinoma, is cancer in the prostate gland (a reproductive gland in men that produces seminal fluid). Symptoms include difficulty with urination, weak or interrupted flow of urine, trouble emptying the bladder completely, and pain or burning sensation during urination.